Literature DB >> 14745722

Normal and pathological human testes express hormone-sensitive lipase and the lipid receptors CLA-1/SR-BI and CD36.

Maria I Arenas1, Maria V T Lobo, Enrique Caso, Lidia Huerta, Ricardo Paniagua, Martin A Martín-Hidalgo.   

Abstract

Numerous studies have demonstrated the important role of cholesterol and cholesteryl esters in tumor cell proliferation and progression of cancer. However, few studies have focused on the role of lipid transporters and lipases in cancer development and progression. The present study examined the expression of hormone-sensitive lipase (HSL) and the scavenger receptors CLA-1/SR-BI and CD36 in normal human testis and in nontumor and tumor testicular disorders by immunohistochemistry and Western blotting analysis. In normal young testes, immunoreaction to CLA-1/SR-BI was found in the spermatid acrosomic vesicle and on the surface of Sertoli and Leydig cells. HSL was detected in spermatogonia, the Golgi region of spermatocytes, the nucleus of spermatids, and the cytoplasm of both Sertoli and Leydig cells. Elderly testes and testes with hypospermatogenesis showed a similar staining pattern to that of normal young testes except for CD36, which was expressed in Sertoli cells. Cryptorchid testes demonstrated intense labeling to HSL and weak labeling to SR-BI in Sertoli cells (nucleus and cytoplasm) and Leydig cells (cytoplasm). Seminiferous tubules with intratubular germ cell neoplasia exhibited intense immunolabeling to the 3 lipid receptors in the surface of neoplastic cells and to HSL in the nucleus. In seminoma and spermatocytic seminoma, neoplastic cells labeled to HSL but failed to stain with antilipid receptors; in the seminiferous tubules at the periphery of the tumour, Charcot-Böttcher crystalloids of Sertoli cells were strongly positive to CLA-1. Testes with mature teratoma showed a weak reaction to CD36 and SR-BI in some cells of enteric-type glands, and immature teratoma were exclusively immunolabeled with HSL. Western blotting analysis revealed that multiple bands were immunolabeled, with differences seen between normal and pathological testes. The results of this study indicate that the presence of lipid receptors (CLA-1/SR-BI) and hormone-sensitive lipase in Leydig cells suggests a role of these proteins in steroidogenesis. Also, these proteins seem to be involved in spermiogenesis, as their labeling in spermatids suggests. In nonmalignant and malignant pathologies, cholesterol metabolism is probably altered, and HSL labeling in neoplastic germ cell nuclei suggests a still-unknown function of this enzyme, probably related to cell cycle regulation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14745722     DOI: 10.1016/j.humpath.2003.08.015

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  11 in total

1.  Identification and characterization of class B scavenger receptor CD36 from the hard tick, Haemaphysalis longicornis.

Authors:  Kyaw Min Aung; Damdinsuren Boldbaatar; Min Liao; Rika Umemiya-Shirafuji; Sumihiro Nakao; Terushige Matsuoka; Tetsuya Tanaka; Kozo Fujisaki
Journal:  Parasitol Res       Date:  2010-09-25       Impact factor: 2.289

2.  Hormone-sensitive lipase expression and IHC localization in the rat ovary, oviduct, and uterus.

Authors:  María V T Lobo; Lydia Huerta; María Isabel Arenas; Rebeca Busto; Miguel Angel Lasunción; Antonia Martín-Hidalgo
Journal:  J Histochem Cytochem       Date:  2008-09-29       Impact factor: 2.479

3.  HSL-knockout mouse testis exhibits class B scavenger receptor upregulation and disrupted lipid raft microdomains.

Authors:  María Emilia Casado; Lydia Huerta; Ana Isabel Ortiz; Mirian Pérez-Crespo; Alfonso Gutiérrez-Adán; Fredric B Kraemer; Miguel Ángel Lasunción; Rebeca Busto; Antonia Martín-Hidalgo
Journal:  J Lipid Res       Date:  2012-09-17       Impact factor: 5.922

Review 4.  Targeting SR-BI for Cancer Diagnostics, Imaging and Therapy.

Authors:  Maneesha A Rajora; Gang Zheng
Journal:  Front Pharmacol       Date:  2016-09-27       Impact factor: 5.810

Review 5.  Targeting the SR-B1 Receptor as a Gateway for Cancer Therapy and Imaging.

Authors:  Linda K Mooberry; Nirupama A Sabnis; Marlyn Panchoo; Bhavani Nagarajan; Andras G Lacko
Journal:  Front Pharmacol       Date:  2016-12-15       Impact factor: 5.810

Review 6.  SR-BI: Linking Cholesterol and Lipoprotein Metabolism with Breast and Prostate Cancer.

Authors:  Jorge L Gutierrez-Pajares; Céline Ben Hassen; Stéphan Chevalier; Philippe G Frank
Journal:  Front Pharmacol       Date:  2016-10-07       Impact factor: 5.810

7.  HDL mediates reverse cholesterol transport from ram spermatozoa and induces hyperactivated motility.

Authors:  Naomi C Bernecic; Simon P de Graaf; Tamara Leahy; Bart M Gadella
Journal:  Biol Reprod       Date:  2021-06-04       Impact factor: 4.285

8.  Toxicogenomic Screening of Replacements for Di(2-Ethylhexyl) Phthalate (DEHP) Using the Immortalized TM4 Sertoli Cell Line.

Authors:  Thomas C Nardelli; Hanno C Erythropel; Bernard Robaire
Journal:  PLoS One       Date:  2015-10-07       Impact factor: 3.240

9.  Ethyl Pyruvate Ameliorates The Damage Induced by Cyclophosphamide on Adult Mice Testes.

Authors:  Zahra Bakhtiary; Rasoul Shahrooz; Abbas Ahmadi; Farhad Soltanalinejad
Journal:  Int J Fertil Steril       Date:  2016-04-05

Review 10.  Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy.

Authors:  Sangram Raut; Linda Mooberry; Nirupama Sabnis; Ashwini Garud; Akpedje Serena Dossou; Andras Lacko
Journal:  Front Pharmacol       Date:  2018-10-15       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.